UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a ...

Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company announced today that the New England Journal of Medicine (NEJM) published results of the 204-patient, global, ...

The New England Journal of Medicine (NEJM) is an English-language peer-reviewed medical journal published by the Massachusetts Medical Society. It describes itself as the oldest continuously ...

Welcome and thank you for considering the New England Journal of Medicine (NEJM) as a venue for your work. As the oldest continuously-published medical journal, our mission since 1812 has been to ...

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a ...

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

At the New England Journal of Medicine (NEJM), our mission is to publish the best research and information at the intersection of biomedical science and clinical practice. Our highly selective ...

Tuberculosis remains one of the deadliest infectious diseases worldwide, with drug-resistant strains posing a significant ...

About 29 million Americans struggle with alcohol use disorder. Earlier this month, the surgeon general released a new report linking alcohol use to cancer. KYW medical editor Dr. Brian McDonough has ...

Scientists have discovered three powerful new drug regimens that offer more effective treatment for tuberculosis—bringing ...

The research, published Jan. 30 in the New England Journal of Medicine, was led by researchers at Harvard Medical School and other members of the endTB project, a collaboration among Partners In ...